TEVA logo

TEVA Gross Margin

Annual Gross Margin

48.74%
+0.49%+1.02%

December 31, 2024

Summary

Performance

1-Year Change

+1.02%

3-Year Change

+1.92%

5-Year Change

+9.21%

15-Year Change

+0.35%

TEVA Gross Margin Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

43.31%
TEVA annual gross profit margin is higher than 43.31% of companies in Healthcare sector

High & Low

All-time High

57.79%
TEVA annual gross profit margin is currently -15.66% below its historical high of 57.79%

3-Year Low

46.72%
TEVA annual gross profit margin is currently +4.32% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
TEVA previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
TEVA next annual earnings announcement has not yet been scheduled

OtherTEVAprofitabilitymetrics:

Annual Revenue

$16.54 B
TEVA annual revenue is $16.54 billion

Annual Gross Profit

$8.06 B
TEVA annual gross profit is $8.06 billion

Annual Operating Margin

20.33%
TEVA annual operating profit margin is 20.33%

Annual Net Margin

-9.91%
TEVA annual net profit margin is -9.91%

Quarterly Gross Margin

50.13%
+0.53%+1.07%

December 31, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

+8.11%

3-Year Change

+5.76%

5-Year Change

+8.98%

TEVA Quarterly Gross Margin Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

40.43%
TEVA quarterly gross profit margin is higher than 40.43% of companies in Healthcare sector

High & Low

All-time High

59.15%
TEVA quarterly gross profit margin is currently -15.25% below its historical high of 59.15%

3-Year Low

43.20%
TEVA quarterly gross profit margin is currently +16.04% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
TEVA previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 8, 2025
TEVA next earnings announcement is scheduled for May 8, 2025

OtherTEVAprofitabilitymetrics:

Quarterly Revenue

$4.23 B
TEVA quarterly revenue is $4.23 billion

Quarterly Gross Profit

$2.12 B
TEVA quarterly gross profit is $2.12 billion

Quarterly Operating Margin

21.75%
TEVA quarterly operating profit margin is 21.75%

Quarterly Net Margin

-5.13%
TEVA quarterly net profit margin is -5.13%

Gross Margin Formula

Gross Margin =  Gross Profit
Revenue ✕ 100%

Annual Gross Margin

48.74%
TEVA annual gross profit margin is 48.74%

Annual Gross Profit

$8.06 B
TEVA annual gross profit is $8.06 billion

Annual Revenue

$16.54 B
TEVA annual revenue is $16.54 billion

TEVA Gross Margin Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+1.0%+8.1%
3 y3 years+1.9%+5.8%
5 y5 years+9.2%+9.0%

TEVA Gross Margin Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+4.3%-7.5%+16.0%
5 y5-yearat high+9.2%-7.5%+16.0%
alltimeall time-15.7%+37.2%-15.3%+39.6%

Teva Pharmaceutical Industries Limited Gross Margin History

DateAnnualQuarterly
Dec 2024
48.74%(+1.0%)
50.13%(+1.1%)
Sep 2024
-
49.60%(+2.0%)
Jun 2024
-
48.61%(+4.8%)
Mar 2024
-
46.37%(-14.4%)
Dec 2023
48.25%(+3.3%)
54.18%(+12.7%)
Sep 2023
-
48.08%(+3.8%)
Jun 2023
-
46.32%(+7.2%)
Mar 2023
-
43.20%(-5.2%)
Dec 2022
46.72%(-2.3%)
45.58%(-1.8%)
Sep 2022
-
46.43%(-2.0%)
Jun 2022
-
47.40%(-0.3%)
Mar 2022
-
47.53%(-4.9%)
Dec 2021
47.82%(+3.1%)
50.00%(+8.3%)
Sep 2021
-
46.17%(-3.6%)
Jun 2021
-
47.90%(+1.6%)
Mar 2021
-
47.16%(+2.5%)
Dec 2020
46.38%(+3.9%)
46.00%(-1.2%)
Sep 2020
-
46.56%(+2.2%)
Jun 2020
-
45.56%(-3.8%)
Mar 2020
-
47.35%(+8.0%)
Dec 2019
44.63%(-1.7%)
43.83%(-2.0%)
Sep 2019
-
44.71%(-1.4%)
Jun 2019
-
45.33%(+1.3%)
Mar 2019
-
44.76%(-9.7%)
Dec 2018
45.41%(-6.5%)
49.57%(+13.6%)
Sep 2018
-
43.65%(+0.9%)
Jun 2018
-
43.25%(-5.4%)
Mar 2018
-
45.71%(-2.1%)
Dec 2017
48.57%(-8.7%)
46.67%(-1.1%)
Sep 2017
-
47.18%(-5.5%)
Jun 2017
-
49.91%(-0.7%)
Mar 2017
-
50.25%(+2.4%)
Dec 2016
53.20%(-7.9%)
49.05%(-2.6%)
Sep 2016
-
50.35%(-11.8%)
Jun 2016
-
57.11%(-1.6%)
Mar 2016
-
58.02%(-0.5%)
Dec 2015
57.79%(+6.0%)
58.33%(+1.5%)
Sep 2015
-
57.45%(-1.7%)
Jun 2015
-
58.44%(+2.7%)
Mar 2015
-
56.92%(+1.8%)
Dec 2014
54.54%(+3.5%)
55.90%(+0.6%)
Sep 2014
-
55.54%(+5.3%)
Jun 2014
-
52.75%(-2.2%)
Mar 2014
-
53.93%(+1.2%)
Dec 2013
52.71%(+0.5%)
53.30%(+2.5%)
Sep 2013
-
51.99%(-1.3%)
Jun 2013
-
52.66%(-0.4%)
Mar 2013
-
52.85%(-0.4%)
Dec 2012
52.43%(+0.9%)
53.06%(+1.4%)
Sep 2012
-
52.31%(-1.7%)
Jun 2012
-
53.20%(+4.0%)
Mar 2012
-
51.14%(+0.7%)
Dec 2011
51.96%(-7.6%)
50.76%(-1.8%)
Sep 2011
-
51.70%(-1.0%)
Jun 2011
-
52.23%(-2.6%)
Mar 2011
-
53.63%(-3.8%)
Dec 2010
56.23%(+6.1%)
55.77%(-3.9%)
Sep 2010
-
58.05%(+4.0%)
Jun 2010
-
55.82%(+1.3%)
Mar 2010
-
55.11%(-0.2%)
DateAnnualQuarterly
Dec 2009
53.00%(-1.6%)
55.21%(+1.7%)
Sep 2009
-
54.31%(+4.4%)
Jun 2009
-
52.03%(+4.2%)
Mar 2009
-
49.92%(-11.1%)
Dec 2008
53.84%(+3.9%)
56.14%(+6.9%)
Sep 2008
-
52.50%(-1.5%)
Jun 2008
-
53.31%(-0.1%)
Mar 2008
-
53.34%(+2.0%)
Dec 2007
51.84%(+2.3%)
52.29%(-1.0%)
Sep 2007
-
52.83%(+1.4%)
Jun 2007
-
52.10%(+4.5%)
Mar 2007
-
49.86%(+3.0%)
Dec 2006
50.65%(+7.2%)
48.41%(-12.3%)
Sep 2006
-
55.20%(+2.4%)
Jun 2006
-
53.92%(+24.6%)
Mar 2006
-
43.28%(-10.3%)
Dec 2005
47.24%(+1.2%)
48.26%(+2.8%)
Sep 2005
-
46.96%(-0.9%)
Jun 2005
-
47.41%(+2.5%)
Mar 2005
-
46.26%(-0.6%)
Dec 2004
46.66%(+0.6%)
46.54%(-1.5%)
Sep 2004
-
47.27%(+0.5%)
Jun 2004
-
47.03%(+3.0%)
Mar 2004
-
45.65%(-0.7%)
Dec 2003
46.36%(+6.6%)
45.97%(-1.0%)
Sep 2003
-
46.42%(-1.5%)
Jun 2003
-
47.14%(+2.5%)
Mar 2003
-
46.00%(+4.5%)
Dec 2002
43.49%(+6.6%)
44.04%(+2.8%)
Sep 2002
-
42.86%(-0.8%)
Jun 2002
-
43.20%(-1.3%)
Mar 2002
-
43.75%(+3.4%)
Dec 2001
40.79%(-9.3%)
42.30%(+4.0%)
Sep 2001
-
40.68%(+2.0%)
Jun 2001
-
39.87%(-0.6%)
Mar 2001
-
40.12%(-30.8%)
Dec 2000
44.97%(-1.1%)
57.99%(+44.7%)
Sep 2000
-
40.07%(-7.8%)
Jun 2000
-
43.45%(+6.5%)
Mar 2000
-
40.79%(-29.9%)
Dec 1999
45.48%(+5.8%)
58.20%(+45.5%)
Sep 1999
-
40.00%(-2.8%)
Jun 1999
-
41.14%(+4.9%)
Mar 1999
-
39.23%(-33.7%)
Dec 1998
43.00%(-1.6%)
59.15%(+53.0%)
Sep 1998
-
38.67%(+7.7%)
Jun 1998
-
35.90%(-1.7%)
Mar 1998
-
36.52%
Dec 1997
43.69%(+3.3%)
-
Dec 1996
42.29%(+4.0%)
-
Dec 1995
40.65%(-5.1%)
-
Dec 1994
42.85%(-7.9%)
-
Dec 1993
46.51%(+6.8%)
-
Dec 1992
43.53%(+7.1%)
-
Dec 1991
40.66%(-2.8%)
-
Dec 1990
41.85%(+17.2%)
-
Dec 1989
35.72%(-7.6%)
-
Dec 1988
38.65%(-1.4%)
-
Mar 1987
39.18%(+10.3%)
-
Mar 1986
35.53%
-

FAQ

  • What is Teva Pharmaceutical Industries Limited annual gross profit margin?
  • What is the all time high annual gross margin for Teva Pharmaceutical Industries Limited?
  • What is Teva Pharmaceutical Industries Limited annual gross margin year-on-year change?
  • What is Teva Pharmaceutical Industries Limited quarterly gross profit margin?
  • What is the all time high quarterly gross margin for Teva Pharmaceutical Industries Limited?
  • What is Teva Pharmaceutical Industries Limited quarterly gross margin year-on-year change?

What is Teva Pharmaceutical Industries Limited annual gross profit margin?

The current annual gross margin of TEVA is 48.74%

What is the all time high annual gross margin for Teva Pharmaceutical Industries Limited?

Teva Pharmaceutical Industries Limited all-time high annual gross profit margin is 57.79%

What is Teva Pharmaceutical Industries Limited annual gross margin year-on-year change?

Over the past year, TEVA annual gross profit margin has changed by +0.49% (+1.02%)

What is Teva Pharmaceutical Industries Limited quarterly gross profit margin?

The current quarterly gross margin of TEVA is 50.13%

What is the all time high quarterly gross margin for Teva Pharmaceutical Industries Limited?

Teva Pharmaceutical Industries Limited all-time high quarterly gross profit margin is 59.15%

What is Teva Pharmaceutical Industries Limited quarterly gross margin year-on-year change?

Over the past year, TEVA quarterly gross profit margin has changed by +3.76% (+8.11%)